Login
$RNAC
$6.46 +$0.18 (2.87%) Close

Company Executives

Officer Age In this role Joined 2025 pay Source
Carsten Brunn Also a director
President and Chief Executive Officer
55 Not stated Not stated $4,329,868
Blaine Davis
Chief Financial Officer
52 Since 2022
4 years
Not stated $1,949,927
Milos Miljkovic
Chief Medical Officer
42 Since 2023
3 years
Not stated $1,657,535
Emily English
Chief Operations Officer
46 Since 2025
1 year
Not stated Not reported
June Seymour
Chief Accounting Officer
48 Since 2025
1 year
Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
8
serving now
Independent
7 of 8
stated in the proxy
Average tenure
6.0 years
from year joined
CEO also chairs the board
Yes
Carsten Brunn, Ph.D.
Director Age On board Independent Committees Other public boards 2025 pay Source
Carsten Brunn, Ph.D.
55 2018
8 years
Not independent None stated None stated Paid as CEO
Michael Singer, M.D., Ph.D.
52 2023
3 years
Independent
Nominating and Corporate Governance Science and Technology
None stated $197,562
Timothy A. Springer, Ph.D.
78 2016
10 years
Independent
Science and Technology
None stated $192,562
Patrick Zenner, M.B.A.
79 2017
9 years
Independent
Audit Compensation Nominating and Corporate Governance · Chair
None stated $216,910
Adrian Bot, M.D., Ph.D.
58 2025
1 year
Independent
Science and Technology · Chair
None stated $159,107
Kemal Malik, M.B.B.S.
63 2024
2 years
Independent
Compensation · Chair
None stated Not stated
Timothy C. Barabe, M.B.A.
73 2016
10 years
Independent
Audit · Chair Nominating and Corporate Governance
None stated $210,062
Nishan de Silva, M.D., M.B.A.
53 2021
5 years
Independent
Audit Compensation
None stated $202,562

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

8 disclosed in the proxy filed Apr 28, 2026
TAS
affiliate of Dr. Springer
$2.9 million
2024

Exercise of 65,681 warrants to purchase Common Stock at $43.80 per share in cash, receiving shares and contingent value rights

TAS
affiliate of Dr. Springer
Amount not stated
2024

Party to the 2023 securities purchase agreement for Series A Preferred Stock in the 2023 Private Placement

Seven One Eight Three Four Irrevocable Trust
trust associated with Murat Kalayoglu, M.D., Ph.D.
Amount not stated
2024

Party to the 2023 securities purchase agreement for Series A Preferred Stock in the 2023 Private Placement

TAS Partners LLC
affiliate of Timothy A. Springer, Ph.D.
Amount not stated

Purchase of Series B Preferred Stock in the 2024 Private Placement

Chafen Lu, Ph.D.
wife of Timothy A. Springer, Ph.D.
Amount not stated

Purchase of Series B Preferred Stock in the 2024 Private Placement

our directors and executive officers
indemnification agreements with each director and executive officer
Amount not stated

Indemnification agreements requiring the Company to indemnify directors and executive officers to the fullest extent permitted by Delaware law

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support